Marcela Krecmerova

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Johns Hopkins University, Institute of Organic Chemistry and Biochemistry, Inst of Organic Chem. and Biochemistry as Cr V.v.i. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marcela Krecmerova. Retrieved from https://idiyas.com/inventor/marcela-krecmerova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 3)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 13(Granted Patents)

Company Filing History:

6 out of 3,798

Johns Hopkins University

patents

4 out of 50

Institute of Organic Chemistry and Biochemistry

patents

1 out of 1

Inst of Organic Chem. and Biochemistry as Cr V.v.i

patent

4. 1 out of 4

Institute of Organic Chemistry and Biochemistry as Cr V.V.I.

patents

5. 1 out of 84

K.u. Leuven Research & Development

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12643846 - Prodrugs of itaconate and methyl itaconate (2026-06-02),

2. 12492160 - Prodrugs of itaconate and methyl itaconate (2025-12-09),

3. 11932664 - Prodrugs of prostate specific membrane antigen (PSMA) inhibitor (2024-03-19),

4. 11325931 - Prodrugs of prostate specific membrane antigen (PSMA) inhibitor (2022-05-10),

5. 10544176 - Prodrugs of prostate specific membrane antigen (PSMA) inhibitor (2020-01-28),

6. 9988407 - Prodrugs of prostate specific membrane antigen (PSMA) inhibitor (2018-06-05),

7. 8153787 - Azacytosine derivatives useful as antiviral agents (2012-04-10),

Title: The Innovative Contributions of Marcela Krecmerova

Introduction

Marcela Krecmerova is a distinguished inventor based in Prague, Czech Republic. She has made significant contributions to the field of medicine, particularly in the development of prodrugs for treating diseases related to prostate-specific membrane antigen (PSMA). With a total of five patents to her name, her work is recognized for its potential impact on therapeutic strategies.

Latest Patents

Among her latest patents, Krecmerova has developed methods and compounds for treating diseases by inhibiting PSMA using prodrugs of 2-PMPA. This innovative approach aims to enhance the efficacy of treatments targeting prostate cancer, showcasing her commitment to advancing medical science.

Career Highlights

Krecmerova has had a notable career, working with prestigious institutions such as The Johns Hopkins University and the Institute of Organic Chemistry and Biochemistry ASCR, v.v.i. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Throughout her career, Krecmerova has worked alongside esteemed colleagues, including Barbara S. Slusher and Rana Rais. These collaborations have further enriched her research and innovation efforts.

Conclusion

Marcela Krecmerova's contributions to the field of medicine through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in cancer treatment and demonstrates the importance of innovation in healthcare.

Profile summary based on public USPTO records.